{"id":31948,"date":"2025-03-17T13:43:20","date_gmt":"2025-03-17T12:43:20","guid":{"rendered":"https:\/\/ggba.swiss\/?p=31948"},"modified":"2025-03-17T13:43:21","modified_gmt":"2025-03-17T12:43:21","slug":"western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/","title":{"rendered":"Western Switzerland innovators PeriVision, Bioscibex and Carewell receive support from FIT"},"content":{"rendered":"\n

Western Switzerland continues to foster cutting-edge innovation in healthcare and biotechnology, with start-ups playing a crucial role in addressing key industry challenges. From AI-powered vision diagnostics to next-generation biopharmaceutical production and digital solutions for healthcare staffing, emerging companies are developing transformative technologies. With the support of the Foundation for Technological Innovation (FIT<\/a>), these start-ups are accelerating their growth, bringing impactful solutions to market, and strengthening the region\u2019s position as a global leader in healthtech and biotech innovation.<\/p>\n\n\n\n

PeriVision: AI-driven vision testing for faster diagnoses<\/h4>\n\n\n\n

Ophthalmology faces increasing challenges as age-related eye diseases rise while the number of specialists remains insufficient. Traditional vision tests are time-consuming, costly, and prone to inaccuracies, contributing to delays in diagnosis and treatment.<\/p>\n\n\n\n

PeriVision<\/a> has developed a virtual reality headset equipped with artificial intelligence-driven software, which delivers more accurate vision tests in a fraction of the time. The system enhances patient throughput by 30%, improving both diagnostics and early disease detection.<\/p>\n\n\n\n

With a CHF 300,000 Tech Growth loan, PeriVision will expand its customer base and develop new functionalities, including advanced diagnostic and predictive algorithms.<\/p>\n\n\n\n

Bioscibex: transforming biopharmaceutical production<\/h4>\n\n\n\n

Biopharmaceuticals are revolutionizing cancer and autoimmune disease treatments, but high production costs remain a barrier to accessibility. The traditional drug manufacturing process is complex, involving seven sequential steps that drive up costs and increase contamination risks.<\/p>\n\n\n\n

Bioscibex<\/a> has developed an innovative bioreactor that reduces these steps to just two, significantly cutting production time and costs. The company\u2019s scalable technology allows cell expansion from 30 mL to 30 L in a single process, making it one of the most efficient bioreactors on the market.<\/p>\n\n\n\n

FIT\u2019s CHF 100,000 Tech Seed loan will support the development of a beta prototype, which is set to be tested by customers by mid-2025.<\/p>\n\n\n\n

Carewell: a digital solution for Switzerland\u2019s healthcare workforce crisis<\/h4>\n\n\n\n

Switzerland is experiencing a severe shortage of healthcare professionals, with 12,000 vacancies and absence rates reaching 20%. Meanwhile, over 60,000 former healthcare professionals remain outside the workforce due to a lack of flexible employment opportunities.<\/p>\n\n\n\n

Carewell<\/a>\u2019s digital platform addresses this gap by connecting hospitals and care facilities with qualified professionals seeking flexible roles. Using AI-powered job matching, the platform streamlines recruitment while improving staff retention and job satisfaction.<\/p>\n\n\n\n

Following a CHF 20,000 grant in 2024, FIT has provided a CHF 50,000 Digital Seed loan to help Carewell expand its platform, enhance marketing efforts, and onboard more freelance healthcare professionals.<\/p>\n\n\n\n

By supporting PeriVision, Bioscibex, and Carewell, FIT reinforces Western Switzerland\u2019s role as a leader in healthcare and biotech innovation. These start-ups are set to enhance diagnostics, lower drug production costs, and address workforce shortages, contributing to a more efficient and accessible healthcare system.<\/p>\n","protected":false},"excerpt":{"rendered":"

The Foundation for Technological Innovation (FIT) has awarded funding to promising Western Switzerland start-ups PeriVision, Bioscibex, and Carewell, to accelerate their development in healthtech and biotechnology.<\/p>\n","protected":false},"author":6,"featured_media":31949,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[893,912,949,894,963,926,902],"class_list":["post-31948","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-artificial-intelligence","tag-biotech","tag-education-en","tag-financing","tag-medical-devices","tag-medtech","tag-personalized-medicine"],"acf":[],"yoast_head":"\nPeriVision, Bioscibex and Carewell receive support from FIT<\/title>\n<meta name=\"description\" content=\"The FIT has awarded funding to PeriVision, Bioscibex, and Carewell, to accelerate their development in healthtech and biotechnology.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PeriVision, Bioscibex and Carewell receive support from FIT\" \/>\n<meta property=\"og:description\" content=\"The FIT has awarded funding to PeriVision, Bioscibex, and Carewell, to accelerate their development in healthtech and biotechnology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-17T12:43:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-17T12:43:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Western Switzerland innovators PeriVision, Bioscibex and Carewell receive support from FIT\",\"datePublished\":\"2025-03-17T12:43:20+00:00\",\"dateModified\":\"2025-03-17T12:43:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/\"},\"wordCount\":446,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png\",\"keywords\":[\"Artificial Intelligence\",\"Biotech\",\"Education\",\"Financing\",\"Medical Devices\",\"Medtech\",\"Personalized Medicine\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/\",\"url\":\"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/\",\"name\":\"PeriVision, Bioscibex and Carewell receive support from FIT\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png\",\"datePublished\":\"2025-03-17T12:43:20+00:00\",\"dateModified\":\"2025-03-17T12:43:21+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"The FIT has awarded funding to PeriVision, Bioscibex, and Carewell, to accelerate their development in healthtech and biotechnology.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png\",\"width\":1180,\"height\":811,\"caption\":\"PeriVision, Bioscibex, and Carewell have received a total of CHF 450,000 in loans to enhance their innovative solutions in vision diagnostics, biopharmaceutical production, and healthcare staffing. | \u00a9 FIT\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Western Switzerland innovators PeriVision, Bioscibex and Carewell receive support from FIT\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PeriVision, Bioscibex and Carewell receive support from FIT","description":"The FIT has awarded funding to PeriVision, Bioscibex, and Carewell, to accelerate their development in healthtech and biotechnology.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/","og_locale":"en_US","og_type":"article","og_title":"PeriVision, Bioscibex and Carewell receive support from FIT","og_description":"The FIT has awarded funding to PeriVision, Bioscibex, and Carewell, to accelerate their development in healthtech and biotechnology.","og_url":"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-03-17T12:43:20+00:00","article_modified_time":"2025-03-17T12:43:21+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png","type":"image\/png"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Western Switzerland innovators PeriVision, Bioscibex and Carewell receive support from FIT","datePublished":"2025-03-17T12:43:20+00:00","dateModified":"2025-03-17T12:43:21+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/"},"wordCount":446,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png","keywords":["Artificial Intelligence","Biotech","Education","Financing","Medical Devices","Medtech","Personalized Medicine"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/","url":"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/","name":"PeriVision, Bioscibex and Carewell receive support from FIT","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png","datePublished":"2025-03-17T12:43:20+00:00","dateModified":"2025-03-17T12:43:21+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"The FIT has awarded funding to PeriVision, Bioscibex, and Carewell, to accelerate their development in healthtech and biotechnology.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/03\/PeriVision-Bioscibex-Carewell-1180x811-1.png","width":1180,"height":811,"caption":"PeriVision, Bioscibex, and Carewell have received a total of CHF 450,000 in loans to enhance their innovative solutions in vision diagnostics, biopharmaceutical production, and healthcare staffing. | \u00a9 FIT"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/western-switzerland-innovators-perivision-bioscibex-and-carewell-receive-support-from-fit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Western Switzerland innovators PeriVision, Bioscibex and Carewell receive support from FIT"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/31948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=31948"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/31948\/revisions"}],"predecessor-version":[{"id":31953,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/31948\/revisions\/31953"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/31949"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=31948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=31948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=31948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}